Related by context. Frequent words. (Click for all words.) 75 secondary efficacy endpoints 70 noninferiority 69 primary efficacy endpoint 69 secondary endpoint 69 efficacy endpoints 69 clinical endpoints 68 composite endpoint 68 primary endpoint 67 phase IIa 66 primary efficacy endpoints 66 prespecified 66 subgroup analyzes 65 Phase 2a trial 65 secondary endpoints 64 Phase 2b study 64 placebo controlled clinical 64 phase IIb 64 elagolix 64 primary endpoints 63 nab paclitaxel 63 phase 2a 63 Phase IIa trial 62 SinuNase 62 virologic response 62 HuMax CD# 62 alvimopan 62 PROMACTA 62 active comparator 62 double blinded placebo 62 dose limiting toxicities 62 Phase 2a clinical 61 aflibercept 61 TRITON TIMI 61 midstage study 61 non inferiority 61 tocilizumab 61 methylnaltrexone 61 Northera 61 statistical significance 61 Phase IIa clinical 61 tipranavir 61 virologic failure 61 biologic therapy 61 Zerenex 61 Gabapentin GR 60 dose cohorts 60 Torisel 60 teduglutide 60 MAP# 60 Phase IIb clinical 60 diabetic neuropathic pain 60 tolerated dose MTD 60 adalimumab 60 CoFactor 60 Synavive 60 muraglitazar 60 decitabine 60 AZD# 60 relapsed refractory multiple myeloma 60 limiting toxicity 60 BAY #-# 60 pharmacodynamic 60 LIALDA 60 PegIntron 60 ocrelizumab 60 ozarelix 60 cytogenetic response 60 eculizumab 60 cardiovascular morbidity 60 unblinded 60 Phase 2a 60 6R BH4 59 Phase 1b 59 Phase IIa 59 mg kg dose 59 Neuradiab 59 sunitinib 59 Phenoptin 59 romiplostim 59 pregabalin 59 HER2 positive metastatic breast 59 prospective randomized controlled 59 PS# [001] 59 confirmatory Phase III 59 sustained virologic response 59 bosentan 59 eltrombopag 59 FOLFIRI 59 Phase 2b trial 59 CA4P 59 placebo controlled studies 59 temsirolimus 59 Phase Ib 59 administered subcutaneously 59 vandetanib 59 TRIOLEX 59 Phase 1b trial 58 peginterferon 58 median PFS 58 #mg dose [003] 58 Secondary endpoints